Trade

with

Biolase Inc
(NASDAQ: BIOL)
AdChoices
2.36
+0.06
+2.61%
After Hours :
-
-
-

Open

2.33

Previous Close

2.30

Volume (Avg)

51.54k (203.88k)

Day's Range

2.32-2.36

52Wk Range

1.47-3.53

Market Cap.

100.94M

Dividend Rate ( Yield )

-

Beta

2.55

Shares Outstanding

43.89M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 56.43M

    • Net Income

    • -11.48M

    • Market Cap.

    • 100.94M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -35.73

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 2.55

    • Forward P/E

    • -

    • Price/Sales

    • 1.63

    • Price/Book Value

    • 34.72

    • Price/Cash flow

    • -11.33

      • EBITDA

      • -10.40M

      • Return on Capital %

      • -59.83

      • Return on Equity %

      • -318.17

      • Return on Assets %

      • -59.83

      • Book Value/Share

      • 0.07

      • Shares Outstanding

      • 43.89M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.01 (6/24/2005)

      • Dividend Declaration Date

      • 6/16/2005

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 5.00

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -28.50

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -

          • -15.59

          • Net Income

            Q/Q (last year)

          • -

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • -2.68

          • 12.51

          • Net Income

            5-Year Annual Average

          • -

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 36.20

            • 52.83

            • Pre-Tax Margin

            • -35.54

            • 15.96

            • Net Profit Margin

            • -35.73

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 41.60

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -17.40

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • -17.50

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 0.95

              • 1.97

              • Quick Ratio

              • 0.38

              • 1.16

              • Interest Coverage

              • -

              • 10.47

              • Leverage Ratio

              • 9.09

              • 2.38

              • Book Value/Share

              • 0.07

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -4.57

                • 36.10

                • P/E Ratio 5-Year High

                • -12.82

                • 279.76

                • P/E Ratio 5-Year Low

                • -1.12

                • 148.87

                • Price/Sales Ratio

                • 1.63

                • 3.35

                • Price/Book Value

                • 34.72

                • 4.19

                • Price/Cash Flow Ratio

                • -11.33

                • 17.36

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -318.17

                    (-151.80)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • -59.83

                    (-27.00)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • -172.93

                    (-102.70)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • -

                  • 25.65k

                  • Inventory Turnover

                  • 2.58

                  • 2.66

                  • Asset Turnover

                  • 1.67

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -11.00M
                  Operating Margin
                  -19.49
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -11.33
                  Ownership

                  Institutional Ownership

                  43.18%

                  Top 10 Institutions

                  45.78%

                  Mutual Fund Ownership

                  5.17%

                  Float

                  75.62%

                  5% / Insider Ownership

                  4.93%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    599,355

                  • 0.00

                  • 1.37

                  • Vanguard Extended Market Index Fund

                  •  

                    466,311

                  • 0.00

                  • 1.06

                  • TETON Westwood Mighty Mites Fund

                  •  

                    342,341

                  • 0.00

                  • 0.91

                  • Vanguard Instl Total Stock Market Index

                  •  

                    281,018

                  • 0.00

                  • 0.64

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    117,156

                  • 0.00

                  • 0.27

                  • iShares Micro-Cap

                  •  

                    95,716

                  • 0.84

                  • 0.20

                  • EQ/GAMCO Small Company Value

                  •  

                    91,461

                  • 0.00

                  • 0.21

                  • Gabelli Small Cap Growth Fund

                  •  

                    45,678

                  • 0.00

                  • 0.12

                  • Vanguard Balanced Index Fund

                  •  

                    38,372

                  • 0.00

                  • 0.09

                  • Fidelity Spartan® Total Market Idx Fund

                  •  

                    31,172

                  • 0.00

                  • 0.07

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Oracle Investment Management Inc

                  •  

                    8,406,746

                  • +37.01%

                  • 22.34

                  • Camber Capital Management LLC

                  •  

                    2,715,119

                  • 0.00%

                  • 7.21

                  • Brecken Capital LLC

                  •  

                    1,577,000

                  • -23.07%

                  • 4.93

                  • Vanguard Group, Inc.

                  •  

                    1,331,128

                  • -3.43%

                  • 3.54

                  • BlackRock Fund Advisors

                  •  

                    1,186,332

                  • -19.33%

                  • 3.15

                  • Princeton Capital Management Inc

                  •  

                    451,099

                  • +2.51%

                  • 1.20

                  • Teton Advisors, Inc.

                  •  

                    342,339

                  • 0.00%

                  • 0.91

                  • Northern Trust Investments, N.A.

                  •  

                    342,022

                  • -18.35%

                  • 0.91

                  • Perkins Capital Management Inc

                  •  

                    337,408

                  • -5.43%

                  • 0.90

                  • Eagle Asset Management, Inc.

                  •  

                    301,578

                  • 0.00%

                  • 0.69

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Speculative Growth

                  Style

                  Small Core

                  Biolase Inc was originally formed as Societe Endo Technic, SA (“SET”) in 1984 in Marseilles, France. In 1987, SET merged into Pamplona Capital Corp., a public holding company incorporated in Delaware. In 1994, it changed its name to ...moreBIOLASE Technology, Inc. and to BIOLASE, Inc. (“BIOLASE”) in 2012. The Company is a biomedical company that develops, manufactures, and markets lasers in dentistry and medicine and also markets and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners, and in-office, chair-side milling machines and three-dimensional (“3-D”) printers; products that are focused on technologies that advance the practice of dentistry and medicine. Its proprietary dental laser systems allows dentists, periodontists, endodontists, oral surgeon...mores, and other specialists to perform a dental procedures, including cosmetic, restorative, and complex surgical applications. Its systems are designed to provide performance for many types of dental procedures with less pain and faster recovery times than are generally achieved with drills, scalpels, and other conventional instruments. The Company has clearance from the U.S. Food and Drug Administration (the “FDA”) to sell its laser systems in the United States and also have the necessary registration to sell its laser systems in Canada, the European Union, and various other international markets. Its licensed dental imaging equipment and other related products are designed to improve diagnoses, applications, and procedures in dentistry and medicine. It offers two categories of laser system products: WaterLase systems and Diode systems. Its WaterLase system, uses a patented combination of water and laser energy to perform most procedures currently performed using dental drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. It currently has approximately 180 issued and 120 pending U.S. and international patents, the majority of which are related to WaterLase technology and dental and medical lasers.lessless

                  Key People

                  Jeffrey M. Nugent

                  Director/CEO/President

                  Paul N. Clark

                  Director/Chairman of the Board

                  Mr. Frederick D. Furry

                  CFO/Chief Accounting Officer

                  Dr. Jonathan T. Lord,M.D.

                  Director

                  Dr. Frederic H. Moll,M.D.

                  Director

                  • Biolase Inc

                  • 4 Cromwell

                  • Irvine, CA 92618

                  • USA.Map

                  • Phone: +1 949 361-1200

                  • Fax: +1 949 273-6677

                  • biolase.com

                  Incorporated

                  1987

                  Employees

                  220

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: